Derek Wallace

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

Arunee Sabchareon, Derek Wallace, Chukiat Sirivichayakul et al. · The Lancet · 2012 · 814 citations

Veterinary Medicine, Child Health, Infectious Diseases +17

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

Shibadas Biswal, Humberto Reynales, Xavier Sáez‐Llorens et al. · New England Journal of Medicine · 2019 · 389 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)

Luis Rivera, Shibadas Biswal, Xavier Sáez‐Llorens et al. · Clinical Infectious Diseases · 2021 · 236 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

Vianney Tricou, Delia Yu, Humberto Reynales et al. · The Lancet Global Health · 2024 · 225 citations · Full text

Veterinary Medicine, Child Health, Infectious Diseases +17

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

Eduardo López‐Medina, Shibadas Biswal, Xavier Sáez‐Llorens et al. · The Journal of Infectious Diseases · 2020 · 106 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17